HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effect of the ethanol extract from Ligusticum chuanxiong rhizome against streptozotocin-induced diabetic nephropathy in mice.

AbstractETHNOPHARMACOLOGY RELEVANCE:
Rhizome of Ligusticum chuanxiong Hort. (Abbreviated as LC) is a frequently prescribed component in plenty of traditional Chinese medicine (TCM) formulas which are used to treat diabetic nephropathy (DN). The aims of the present study are to investigate the protective effect of the ethanol extract of LC rhizome (EEL) against DN in vivo, evaluate its potential mechanism, and find the evidence supporting its enthopharmacological use as an anti-DN agent.
MATERIALS AND METHODS:
Hepa 1c1c7 murine hepatoma cells, human breast carcinoma MDA-MB-231 cells, human renal glomerular endothelial cells (HRGEC), and RAW 264.7 murine macrophages were adopted to test the effects of EEL and its active constituents on inhibitions of oxidative stress and inflammation in vitro. A streptozotocin (STZ) -induced DN C57BL/6 mice model was established and used to investigate the preventive effect of EEL against DN in vivo.
RESULTS:
EEL demonstrated potential inhibitory effects against oxidative stress and inflammation in vitro. Using a STZ-induced DN mice model, it has been found that EEL treatment significantly prevented STZ-induced increases of urine production, urinary albumin excretion (UAE) and urine albumin-to-creatinine ratio (UACR), and markedly attenuated STZ-induced renal damages (e.g. glomerulosclerosis and fibrosis). The predominant bioactive constituents, Z-ligustilide (LGT), ferulic acid (FA), and tetramethylpyrazine (TMP), were inhibitors of oxidative stress and inflammation through acting with Nrf2 and NF-κB pathways.
CONCLUSIONS:
EEL attenuates structural and functional damages of kidney in STZ-induced DN model in vivo, which might be related to the functions of EEL on inhibitions of oxidative stress and inflammation. These finding definitely supports the ethnopharmacological use of LC as an anti-DN agent.
AuthorsWen-Jing Yang, Yan-Ru Li, Hui Gao, Xue-Yi Wu, Xiao-Ling Wang, Xiao-Ning Wang, Lan Xiang, Dong-Mei Ren, Hong-Xiang Lou, Tao Shen
JournalJournal of ethnopharmacology (J Ethnopharmacol) Vol. 227 Pg. 166-175 (Dec 05 2018) ISSN: 1872-7573 [Electronic] Ireland
PMID30176347 (Publication Type: Journal Article)
CopyrightCopyright © 2018 Elsevier B.V. All rights reserved.
Chemical References
  • Anti-Inflammatory Agents
  • Antioxidants
  • NF-E2-Related Factor 2
  • NF-kappa B
  • Nfe2l2 protein, mouse
  • Plant Extracts
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology, therapeutic use)
  • Antioxidants (pharmacology, therapeutic use)
  • Cell Line
  • Cell Survival (drug effects)
  • Diabetes Mellitus, Experimental (drug therapy, metabolism, pathology)
  • Diabetic Nephropathies (drug therapy, metabolism, pathology)
  • Humans
  • Ligusticum
  • Male
  • Mice
  • Mice, Inbred C57BL
  • NF-E2-Related Factor 2 (metabolism)
  • NF-kappa B (metabolism)
  • Phytotherapy
  • Plant Extracts (pharmacology, therapeutic use)
  • Rhizome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: